Femring
Product Images NDC 72495-301

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Femring (NDC 72495-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Millicent Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Estradiol Acetate Is Chemically Described As Estra-1,3,5(10)-triene-3,17b-diol-3-acetate (Femring 01)

Chemical structure of estradiol acetate, the active ingredient in Femring. The structure shows the steroid backbone with acetate and hydroxyl functional groups.*

FDA Label Image

Figure 1. Mean Serum Estradiol Concentrations Following Multiple Dose Administration Of Femring (0.05 mg/day Estradiol) (second Dose Administered At 13 Weeks) (inset: Mean (±sd) Of Serum Concentrati (Femring 02)

A line graph depicting serum estradiol concentration (pg/mL) over time in weeks (0 to 17 weeks) for a study involving Femring (estradiol acetate). The graph shows an initial peak, a decline to low steady levels, and a sharp increase at about week 13. An inset graph shows serum estradiol concentration over 24 hours, with a rapid early decline. The chart illustrates blood hormone levels following administration.*

FDA Label Image

Step 3. Choose The Position That Is Most Comfortable For You. For Example, Lying Down Or Standing With 1 Leg Up (see Figures A And B). (Femring 03)

Illustration showing two recommended positions for vaginal insertion of Femring (estradiol acetate vaginal ring). Figure A depicts a woman lying down with knees bent and feet flat, while Figure B shows a woman standing with one foot elevated on a surface, demonstrating proper placement positions for the ring.*

FDA Label Image

Use Your Thumb And Index Finger (pointer Finger) To Press The Sides Of The Ring Together. You May Find It Easier To Insert Femring If You Twist It Into A Figure-eight Shape (see Figure C). (Femring 04)

An illustration showing a hand holding a small, flexible vaginal ring, representing the Femring estradiol acetate vaginal ring dosage form. The depiction highlights the shape and size suitable for vaginal insertion.*

FDA Label Image

Use Your Other Hand And Hold Open The Folds Of Skin Around Your Vagina (see Figure D). (Femring 05)

An illustration showing placement of a vaginal ring, representing Femring, a vaginal ring dosage form of estradiol acetate used for hormone therapy. The diagram highlights the correct position inside the female lower abdomen for insertion.*

FDA Label Image

Place The Tip Of The Ring In The Vaginal Opening. Use Your Index Finger To Push The Folded Ring Gently Into Your Vagina. Push It Up Towards Your Lower Back As Far As You Can (see Figure E). (Femring 06)

An instructional illustration showing the insertion of a vaginal ring, depicting a hand positioning the ring inside the vaginal canal, with anatomical outline of the female pelvic area visible in the background.*

FDA Label Image

If The Ring Feels Uncomfortable, You May Not Have Pushed The Ring Into Your Vagina Far Enough. Use Your Index Finger To Push The Ring As Far As You Can Into Your Vagina (see Figure F). (Femring 07)

An instructional illustration showing the vaginal insertion of a Femring contraceptive ring. The diagram depicts a hand placing the ring into the vaginal canal, demonstrating the correct method of use for the vaginal ring dosage form of estradiol acetate.*

FDA Label Image

Femring Should Now Be In Your Upper Vagina (see Figure G). The Exact Position Of Femring In The Vagina Is Not Important For It To Work. (Femring 08)

An anatomical illustration showing the female pelvic region with a schematic of the vaginal ring in place, highlighting its location relative to the uterus and surrounding structures. This image is related to Femring, a vaginal ring dosage form containing estradiol acetate.*

FDA Label Image

Put A Finger Into Your Vagina And Hook It Through The Ring (see Figure H (Femring 09)

An instructional diagram showing the insertion of a vaginal ring. The diagram depicts a hand placing the ring into the vaginal canal, illustrating the proper placement for the drug delivery system.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.05 mg/day Carton Label (Femring 10)

Packaging label for Femring estradiol acetate vaginal ring 0.05 mg/day by Millicent US, Inc. The label is bright pink with a flower image on the front panel. Dosage strength and product form as a vaginal ring are clearly indicated. Label includes barcode, manufacturer details, prescribing information direction, and regulatory markings.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.05 mg/day Pouch Label (Femring 11)

Femring estradiol acetate vaginal ring with a dosage of 0.05 mg/day visible on the label. The packaging includes usage instructions, contents of one vaginal ring, and notes it is for intravaginal use only. The label displays the Millicent Pharma logo and indicates the product is prescription-only (Rx Only).*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.10 mg/day Carton Label (Femring 12)

Packaging label for Femring estradiol acetate vaginal ring 0.10 mg/day by Millicent US, Inc. The label is predominantly purple with a close-up image of a flower. It includes the product name, strength, dosage form, and instructions for use, along with manufacturer and reporting information.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.10 mg/day Pouch Label (Femring 13)

Label for Femring estradiol acetate vaginal ring, delivering 0.10 mg per day. The label states it contains one vaginal ring and includes the manufacturer Millicent Pharma Limited. It notes the ring contains 24.8 mg estradiol acetate for a three-month supply and is for intravaginal use only.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.05 mg/day Carton Label-physicians Sample (Femring 14)

Carton packaging label for Femring 0.05 mg/day estradiol acetate vaginal ring by Millicent US, Inc. The label is bright pink featuring an image of a flower center and includes directions stating 'Physician's Sample Not for Sale.' It shows the product name, strength, dosage form, manufacturer, and storage instructions.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.05 mg/day Pouch Label-physicians Sample (Femring 15)

Label for Femring 0.05 mg/day (estradiol acetate vaginal ring) by Millicent Pharma. The label states the product contains 12.4 mg estradiol acetate to deliver 0.05 mg estradiol per day for three months. It is a prescription vaginal ring for intravaginal use only with a physician's sample notice and Rx only designation.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.10 mg/day Carton Label-physicians Sample (Femring 16)

Packaging label for Femring 0.10 mg/day estradiol acetate vaginal ring by Millicent US, Inc. The label is primarily purple with a close-up image of a blue and yellow flower on the front. It features the product name, strength, and dosage form prominently, with text indicating it is a physician's sample not for sale. Additional information includes storage instructions and manufacturer details.*

FDA Label Image

Femring (estradiol Acetate Vaginal Ring) 0.10 mg/day Pouch Label-physicians Sample (Femring 17)

Packaging label for Femring estradiol acetate vaginal ring, delivering 0.10 mg per day. The label indicates the ring contains 24.8 mg estradiol acetate and is for intravaginal use only. It is marked as a physician's sample, not for sale, and produced by Millicent Pharma. The label includes the Rx only designation and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.